Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.41% | 198.20 | 1.2% | $509.37m | |
| GILD | Gilead Sciences, Inc. | 0.11% | 73.67 | 0.9% | $447.54m | |
| BIIB | Biogen Inc. | 0.15% | 331.45 | 1.3% | $369.16m | |
| CELG | Celgene Corporation | 0.10% | 82.66 | 1.2% | $330.77m | |
| ILMN | Illumina, Inc. | -1.09% | 318.19 | 3.5% | $287.29m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.03% | 380.19 | 2.6% | $221.63m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.79% | 122.90 | 2.0% | $210.39m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.74% | 179.98 | 1.9% | $201.98m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.45% | 133.70 | 16.4% | $170.50m | |
| A | Agilent Technologies, Inc. | -0.08% | 66.19 | 1.5% | $154.43m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.94% | 100.44 | 4.4% | $129.55m | |
| VKTX | Viking Therapeutics, Inc. | -1.04% | 14.31 | 0.9% | $107.63m | |
| LGND | Ligand Pharmaceuticals Incorporated | -1.28% | 200.00 | 23.3% | $106.76m | |
| NKTR | Nektar Therapeutics | 1.13% | 49.46 | 5.6% | $106.65m | |
| NBIX | Neurocrine Biosciences, Inc. | -0.24% | 111.21 | 5.1% | $96.74m |
Company Profile
CRISPR Therapeutics AG engages in the development and commercializtion of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.